Suppr超能文献

腺相关病毒(AAV)装配激活蛋白并非AAV血清型4、5和11衣壳装配的必需条件。

Adeno-associated Virus (AAV) Assembly-Activating Protein Is Not an Essential Requirement for Capsid Assembly of AAV Serotypes 4, 5, and 11.

作者信息

Earley Lauriel F, Powers John M, Adachi Kei, Baumgart Joshua T, Meyer Nancy L, Xie Qing, Chapman Michael S, Nakai Hiroyuki

机构信息

Department of Molecular Microbiology and Immunology, Oregon Health & Science University School of Medicine, Portland, Oregon, USA.

Department of Molecular and Medical Genetics, Oregon Health & Science University School of Medicine, Portland, Oregon, USA.

出版信息

J Virol. 2017 Jan 18;91(3). doi: 10.1128/JVI.01980-16. Print 2017 Feb 1.

Abstract

UNLABELLED

Adeno-associated virus (AAV) vectors have made great progress in their use for gene therapy; however, fundamental aspects of AAV's capsid assembly remain poorly characterized. In this regard, the discovery of assembly-activating protein (AAP) sheds new light on this crucial part of AAV biology and vector production. Previous studies have shown that AAP is essential for assembly; however, how its mechanistic roles in assembly might differ among AAV serotypes remains uncharacterized. Here, we show that biological properties of AAPs and capsid assembly processes are surprisingly distinct among AAV serotypes 1 to 12. In the study, we investigated subcellular localizations and assembly-promoting functions of AAP1 to -12 (i.e., AAPs derived from AAV1 to -12, respectively) and examined the AAP dependence of capsid assembly processes of these 12 serotypes using combinatorial approaches that involved immunofluorescence and transmission electron microscopy, barcode-Seq (i. e., a high-throughput quantitative method using DNA barcodes and a next-generation sequencing technology), and quantitative dot blot assays. This study revealed that AAP1 to -12 are all localized in the nucleus with serotype-specific differential patterns of nucleolar association; AAPs and assembled capsids do not necessarily colocalize; AAPs are promiscuous in promoting capsid assembly of other serotypes, with the exception of AAP4, -5, -11, and -12; assembled AAV5, -8, and -9 capsids are excluded from the nucleolus, in contrast to the nucleolar enrichment of assembled AAV2 capsids; and, surprisingly, AAV4, -5, and -11 capsids are not dependent on AAP for assembly. These observations highlight the serotype-dependent heterogeneity of the capsid assembly process and challenge current notions about the role of AAP and the nucleolus in capsid assembly.

IMPORTANCE

Assembly-activating protein (AAP) is a recently discovered adeno-associated virus (AAV) protein that promotes capsid assembly and provides new opportunities for research in assembly. Previous studies on AAV serotype 2 (AAV2) showed that assembly takes place in the nucleolus and is dependent on AAP and that capsids colocalize with AAP in the nucleolus during the assembly process. However, through the investigation of 12 different AAV serotypes (AAV1 to -12), we find that AAP is not an essential requirement for capsid assembly of AAV4, -5, and -11, and AAP, assembled capsids, and the nucleolus do not colocalize for all the serotypes. In addition, we find that there are both serotype-restricted and serotype-promiscuous AAPs in their assembly roles. These findings challenge widely held beliefs about the importance of the nucleolus and AAP in AAV assembly and show the heterogeneous nature of the assembly process within the AAV family.

摘要

未标记

腺相关病毒(AAV)载体在基因治疗应用方面取得了巨大进展;然而,AAV衣壳组装的基本方面仍未得到充分表征。在这方面,组装激活蛋白(AAP)的发现为AAV生物学和载体生产的这一关键部分带来了新的启示。先前的研究表明,AAP对组装至关重要;然而,其在组装中的机制作用在不同AAV血清型之间可能存在怎样的差异仍未明确。在此,我们表明AAP的生物学特性和衣壳组装过程在AAV 1至12型血清型之间惊人地不同。在本研究中,我们研究了AAP1至 -12(即分别源自AAV1至 -12的AAP)的亚细胞定位和组装促进功能,并使用涉及免疫荧光和透射电子显微镜、条形码测序(即一种使用DNA条形码和下一代测序技术的高通量定量方法)以及定量斑点印迹分析的组合方法,研究了这12种血清型衣壳组装过程对AAP的依赖性。这项研究表明,AAP1至 -12都定位于细胞核,具有血清型特异性的核仁关联差异模式;AAP和组装好的衣壳不一定共定位;除AAP4、 -5、 -11和 -12外,AAP在促进其他血清型的衣壳组装方面具有通用性;与组装好的AAV2衣壳在核仁中富集相反,组装好的AAV5、 -8和 -9衣壳被排除在核仁之外;而且,令人惊讶的是,AAV4、 -5和 -11衣壳的组装不依赖于AAP。这些观察结果突出了衣壳组装过程中血清型依赖性的异质性,并挑战了当前关于AAP和核仁在衣壳组装中作用的观念。

重要性

组装激活蛋白(AAP)是最近发现的一种腺相关病毒(AAV)蛋白,它促进衣壳组装并为组装研究提供了新的机会。先前对AAV血清型2(AAV2)的研究表明,组装发生在核仁中且依赖于AAP,并且在组装过程中衣壳与AAP在核仁中共定位。然而,通过对12种不同的AAV血清型(AAV1至 -12)的研究,我们发现AAP并非AAV4、 -5和 -11衣壳组装的必要条件,并且对于所有血清型而言,AAP、组装好的衣壳和核仁并不共定位。此外,我们发现在其组装作用中存在血清型受限和血清型通用的AAP。这些发现挑战了关于核仁和AAP在AAV组装中的重要性的广泛观点,并显示了AAV家族内组装过程的异质性。

相似文献

4
The assembly-activating protein promotes capsid assembly of different adeno-associated virus serotypes.
J Virol. 2011 Dec;85(23):12686-97. doi: 10.1128/JVI.05359-11. Epub 2011 Sep 14.
6
Impact of the Assembly-Activating Protein on Molecular Evolution of Synthetic Adeno-Associated Virus Capsids.
Hum Gene Ther. 2019 Jan;30(1):21-35. doi: 10.1089/hum.2018.085. Epub 2018 Dec 18.
7
Structural and Biophysical Analysis of Adeno-Associated Virus Serotype 2 Capsid Assembly Variants.
J Virol. 2023 Jul 27;97(7):e0177222. doi: 10.1128/jvi.01772-22. Epub 2023 Jun 13.
9
Mapping and Engineering Functional Domains of the Assembly-Activating Protein of Adeno-associated Viruses.
J Virol. 2018 Jun 29;92(14). doi: 10.1128/JVI.00393-18. Print 2018 Jul 15.
10
Improved Genome Packaging Efficiency of Adeno-associated Virus Vectors Using Rep Hybrids.
J Virol. 2021 Sep 9;95(19):e0077321. doi: 10.1128/JVI.00773-21. Epub 2021 Jul 21.

引用本文的文献

1
Mapping administration route-dependent transduction profiles of commonly used AAV variants in mice by barcode amplicon sequencing.
Mol Ther Methods Clin Dev. 2025 Apr 14;33(2):101468. doi: 10.1016/j.omtm.2025.101468. eCollection 2025 Jun 12.
2
Protein Carrier Adeno-Associated Virus.
ACS Nano. 2025 Apr 1;19(12):12308-12322. doi: 10.1021/acsnano.5c01498. Epub 2025 Mar 21.
3
Biophysical and structural insights into AAV genome ejection.
J Virol. 2025 Mar 18;99(3):e0089924. doi: 10.1128/jvi.00899-24. Epub 2025 Feb 5.
4
Chromatography in Downstream Processing of Recombinant Adeno-Associated Viruses: A Review of Current and Future Practises.
Biotechnol Bioeng. 2025 May;122(5):1067-1086. doi: 10.1002/bit.28932. Epub 2025 Feb 4.
5
AAV-based gene delivery of antimicrobial peptides to combat drug-resistant pathogens.
Appl Environ Microbiol. 2025 Feb 19;91(2):e0170224. doi: 10.1128/aem.01702-24. Epub 2025 Jan 6.
6
Enhancing gene transfer to renal tubules and podocytes by context-dependent selection of AAV capsids.
Nat Commun. 2024 Dec 30;15(1):10728. doi: 10.1038/s41467-024-54475-9.
7
Clinical and Translational Landscape of Viral Gene Therapies.
Cells. 2024 Nov 19;13(22):1916. doi: 10.3390/cells13221916.
10
Therapeutic Application and Structural Features of Adeno-Associated Virus Vector.
Curr Issues Mol Biol. 2024 Aug 2;46(8):8464-8498. doi: 10.3390/cimb46080499.

本文引用的文献

1
The Status of RPE65 Gene Therapy Trials: Safety and Efficacy.
Cold Spring Harb Perspect Med. 2015 Jan 29;5(9):a017285. doi: 10.1101/cshperspect.a017285.
3
Long-term safety and efficacy of factor IX gene therapy in hemophilia B.
N Engl J Med. 2014 Nov 20;371(21):1994-2004. doi: 10.1056/NEJMoa1407309.
4
Recombinant adeno-associated virus utilizes host cell nuclear import machinery to enter the nucleus.
J Virol. 2014 Apr;88(8):4132-44. doi: 10.1128/JVI.02660-13. Epub 2014 Jan 29.
6
Viruses and the nucleolus: the fatal attraction.
Biochim Biophys Acta. 2014 Jun;1842(6):840-7. doi: 10.1016/j.bbadis.2013.12.010. Epub 2013 Dec 27.
7
Properties of the adeno-associated virus assembly-activating protein.
J Virol. 2012 Dec;86(23):13038-48. doi: 10.1128/JVI.01675-12. Epub 2012 Sep 26.
8
Effect of alipogene tiparvovec (AAV1-LPL(S447X)) on postprandial chylomicron metabolism in lipoprotein lipase-deficient patients.
J Clin Endocrinol Metab. 2012 May;97(5):1635-44. doi: 10.1210/jc.2011-3002. Epub 2012 Mar 21.
9
Capsid assembly as a point of intervention for novel anti-viral therapeutics.
Curr Pharm Biotechnol. 2013;14(5):513-23. doi: 10.2174/13892010113149990201.
10
The AAV vector toolkit: poised at the clinical crossroads.
Mol Ther. 2012 Apr;20(4):699-708. doi: 10.1038/mt.2011.287. Epub 2012 Jan 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验